| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity | 1.02e-04 | 2 | 202 | 2 | GO:0016316 | |
| GeneOntologyMolecularFunction | inositol-3,4-bisphosphate 4-phosphatase activity | 1.02e-04 | 2 | 202 | 2 | GO:0052828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4-trisphosphate 4-phosphatase activity | 1.02e-04 | 2 | 202 | 2 | GO:0017161 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.18e-04 | 114 | 201 | 7 | GO:0005798 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.37e-04 | 11 | 201 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.37e-04 | 11 | 201 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.37e-04 | 11 | 201 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.37e-04 | 11 | 201 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 3.01e-04 | 61 | 201 | 5 | GO:0030660 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 5.78e-04 | 40 | 201 | 4 | GO:0030140 | |
| Domain | Spectrin | 3.95e-06 | 23 | 201 | 5 | PF00435 | |
| Domain | ACTININ_2 | 3.95e-06 | 23 | 201 | 5 | PS00020 | |
| Domain | ACTININ_1 | 3.95e-06 | 23 | 201 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.95e-06 | 23 | 201 | 5 | IPR001589 | |
| Domain | Spectrin_repeat | 1.32e-05 | 29 | 201 | 5 | IPR002017 | |
| Domain | SPEC | 2.18e-05 | 32 | 201 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.18e-05 | 32 | 201 | 5 | IPR018159 | |
| Domain | RasGAP_dom | 3.54e-05 | 18 | 201 | 4 | IPR001936 | |
| Domain | Clathrin_H-chain_propeller_rpt | 1.15e-04 | 2 | 201 | 2 | IPR022365 | |
| Domain | Clathrin-link | 1.15e-04 | 2 | 201 | 2 | PF09268 | |
| Domain | - | 1.15e-04 | 2 | 201 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 1.15e-04 | 2 | 201 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_propeller_N | 1.15e-04 | 2 | 201 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 1.15e-04 | 2 | 201 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.15e-04 | 2 | 201 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 1.15e-04 | 2 | 201 | 2 | IPR015348 | |
| Domain | ARM-type_fold | CLTCL1 LRRK2 MROH5 ARMC2 LYST NCAPG2 ITPR1 DNAAF5 NF1 PIK3CB CLTC UBR4 | 3.20e-04 | 339 | 201 | 12 | IPR016024 |
| Domain | LRR | 3.37e-04 | 201 | 201 | 9 | PS51450 | |
| Domain | Clathrin_H-chain_linker | 3.43e-04 | 3 | 201 | 2 | IPR012331 | |
| Domain | - | 3.43e-04 | 3 | 201 | 2 | 4.10.1130.10 | |
| Domain | CLH | 3.43e-04 | 3 | 201 | 2 | SM00299 | |
| Domain | Rho_GTPase_activation_prot | 3.76e-04 | 88 | 201 | 6 | IPR008936 | |
| Domain | RasGAP | 4.10e-04 | 14 | 201 | 3 | SM00323 | |
| Domain | RasGAP_CS | 4.10e-04 | 14 | 201 | 3 | IPR023152 | |
| Domain | RasGAP | 5.08e-04 | 15 | 201 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.08e-04 | 15 | 201 | 3 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.08e-04 | 15 | 201 | 3 | PS50018 | |
| Domain | Ankyrin_rpt | RTP1 LRRK2 ANKRD28 ZDHHC13 ANKRD52 ASB14 ZDHHC17 PPP1R16B TNKS2 INVS | 5.64e-04 | 262 | 201 | 10 | IPR002110 |
| Domain | - | 6.20e-04 | 16 | 201 | 3 | 1.10.506.10 | |
| Domain | CH | 6.72e-04 | 65 | 201 | 5 | SM00033 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | IPR012315 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | PS51049 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | SM01249 | |
| Domain | KASH | 6.82e-04 | 4 | 201 | 2 | PF10541 | |
| Domain | CH | 9.43e-04 | 70 | 201 | 5 | PF00307 | |
| Domain | - | 1.01e-03 | 71 | 201 | 5 | 1.10.418.10 | |
| Domain | - | 1.12e-03 | 148 | 201 | 7 | 2.60.40.150 | |
| Domain | GAE | 1.13e-03 | 5 | 201 | 2 | PS50180 | |
| Domain | Toll-like_receptor | 1.13e-03 | 5 | 201 | 2 | IPR017241 | |
| Domain | CH | 1.14e-03 | 73 | 201 | 5 | PS50021 | |
| Domain | CH-domain | 1.29e-03 | 75 | 201 | 5 | IPR001715 | |
| Domain | - | LRRK2 ANKRD28 ZDHHC13 ANKRD52 ASB14 ZDHHC17 PPP1R16B TNKS2 INVS | 1.50e-03 | 248 | 201 | 9 | 1.25.40.20 |
| Domain | - | 1.68e-03 | 6 | 201 | 2 | 2.60.40.1230 | |
| Domain | GAT_dom | 1.68e-03 | 6 | 201 | 2 | IPR004152 | |
| Domain | - | 1.68e-03 | 6 | 201 | 2 | 1.20.58.160 | |
| Domain | Clathrin_g-adaptin_app | 1.68e-03 | 6 | 201 | 2 | IPR008153 | |
| Domain | GAT | 1.68e-03 | 6 | 201 | 2 | PS50909 | |
| Domain | GAT | 1.68e-03 | 6 | 201 | 2 | PF03127 | |
| Domain | Ankyrin_rpt-contain_dom | LRRK2 ANKRD28 ZDHHC13 ANKRD52 ASB14 ZDHHC17 PPP1R16B TNKS2 INVS | 1.77e-03 | 254 | 201 | 9 | IPR020683 |
| Pubmed | ABCF1 CLTCL1 MYCBP2 AGPAT3 PRPF6 TTK MELK NCAPG2 ITPR1 NF1 MDN1 PNPLA6 EIF3L CLTC FEN1 ZDHHC13 DIP2B PSMF1 UBR4 RNF213 CERS6 IGF2R LNPEP GNA13 SERPINB1 OGA GGA1 RPL3L CNOT1 | 6.98e-11 | 1168 | 205 | 29 | 19946888 | |
| Pubmed | ABCF1 MYCBP2 DNAJC21 NBN PRPF6 PLXNB2 TTK NCAPG2 ITPR1 DAP3 PTPN13 MDN1 PNPLA6 SYNE2 CLTC ANKRD28 ANKRD52 STIM2 PDPR GOPC SYNE1 UBR4 SPG11 ZDHHC17 IGF2R LNPEP CTR9 PPA2 POLDIP2 OGA | 4.22e-09 | 1487 | 205 | 30 | 33957083 | |
| Pubmed | MYCBP2 INPP4A GGA3 EIF3L PPP1R37 ANKRD28 ZNF107 SMURF2 TTF2 STIM2 UBR4 ARHGAP5 ZNF41 LNPEP CTR9 TNKS2 GGA1 INVS | 1.69e-08 | 591 | 205 | 18 | 15231748 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ABCF1 MYO5B MYCBP2 AGPAT3 CDH23 TSG101 GOLPH3 PRPF6 ACTN1 MELK NCAPG2 TULP3 DNAAF5 PTPN13 NF1 EIF3L ANKRD28 LCA5 CNOT11 GOPC RADX FANCL USP46 CTR9 GGA1 CNOT1 INVS | 2.09e-08 | 1321 | 205 | 27 | 27173435 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MBTPS1 ABCF1 MYCBP2 DCBLD1 TSG101 EXT1 PLXNB2 NCAPG2 ITPR1 GGH NF1 PTPRS TXNDC16 ZDHHC13 POMT2 STIM2 GOPC RNF213 CERS6 KLHL11 IGF2R PRCP LNPEP SLITRK5 LRP6 | 5.16e-08 | 1201 | 205 | 25 | 35696571 |
| Pubmed | MYO5B MYCBP2 NBN TULP3 ITPR1 PTPN13 PTPRS SSH3 SYNE2 CLTC PPP1R37 ANKRD28 ANKRD52 PDPR GOPC RNF213 USP46 ARHGAP5 IGF2R LNPEP CTR9 LRP6 CNOT1 | 7.32e-08 | 1049 | 205 | 23 | 27880917 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ABCF1 PRPF6 RAD54L2 SRCAP MDN1 CLTC DIP2B UBR4 RNF213 SRRT MTA1 CTR9 MDC1 | 1.03e-07 | 332 | 205 | 13 | 32786267 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.02e-07 | 104 | 205 | 8 | 31240132 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PHYKPL MBTPS1 CDH26 PDE4D MYCBP2 INPP4A SPTB AGPAT3 ARMC2 DNAH14 TULP3 DNAAF5 PTPN13 PNPLA6 PTPRS ZNF107 ZDHHC13 SMURF2 PRUNE2 DIP2B PSMF1 RNF213 CERS6 JMJD1C MSRA CNOT1 INVS | 2.32e-07 | 1489 | 205 | 27 | 28611215 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | PDE4D MYCBP2 EXT1 TULP3 SYNE2 PITPNA TBX3 SATB2 CNOT11 MSRA SRRT MDC1 CNOT1 | 2.45e-07 | 358 | 205 | 13 | 32460013 |
| Pubmed | ABCF1 MYCBP2 PRPF6 ACTN1 NF1 MDN1 SYNE2 EIF3L CLTC ANKRD28 ANKRD52 USP47 UBR4 LCP1 IGF2R MDC1 CNOT1 | 3.94e-07 | 653 | 205 | 17 | 22586326 | |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 12060753 | ||
| Pubmed | ADAMTS19 ERCC2 CLTCL1 GPBP1 MYCBP2 SPTB LRRK2 PLXNB2 DNAH14 ITPR1 NF1 PTPRS FEN1 ANKRD28 SMURF2 FAM76B CPS1 CYRIB TADA1 ZNF100 PPA2 RRN3P1 C1orf94 | 9.49e-07 | 1215 | 205 | 23 | 15146197 | |
| Pubmed | 1.12e-06 | 14 | 205 | 4 | 23378610 | ||
| Pubmed | The GGAs promote ARF-dependent recruitment of clathrin to the TGN. | 2.00e-06 | 5 | 205 | 3 | 11301005 | |
| Pubmed | 2.00e-06 | 5 | 205 | 3 | 14567678 | ||
| Pubmed | Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. | 2.00e-06 | 5 | 205 | 3 | 11859375 | |
| Pubmed | 2.00e-06 | 5 | 205 | 3 | 24407285 | ||
| Pubmed | Sorting of mannose 6-phosphate receptors mediated by the GGAs. | 2.00e-06 | 5 | 205 | 3 | 11387475 | |
| Pubmed | 2.00e-06 | 5 | 205 | 3 | 29358589 | ||
| Pubmed | GGA and Arf proteins modulate retrovirus assembly and release. | 2.00e-06 | 5 | 205 | 3 | 18439901 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ABCF1 GPBP1 MYCBP2 PRPF6 SRCAP MAP3K4 ITPR1 NF1 CLTC MED23 SRRT CTR9 MDC1 | 2.44e-06 | 440 | 205 | 13 | 34244565 |
| Pubmed | MBTPS1 CLTCL1 IRF3 TSG101 PRPF6 MELK INPP4B NF1 MDN1 FEN1 SMURF2 USP46 XPNPEP2 CPS1 TLR10 THRSP CTR9 LRP6 ZNF85 GGA1 TM4SF20 ANO3 INVS | 2.69e-06 | 1293 | 205 | 23 | 15342556 | |
| Pubmed | 3.98e-06 | 6 | 205 | 3 | 15039775 | ||
| Pubmed | NBN IRF3 RAD54L2 SRCAP DAP3 SYNE2 EIF3L ANKRD28 ZNF107 QKI SATB2 CNOT11 RADX UBR4 USP46 JMJD1C SRRT TADA1 MTA1 MDC1 LRP6 ZMYM1 POLDIP2 CNOT1 | 4.29e-06 | 1429 | 205 | 24 | 35140242 | |
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 11390366 | ||
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 28581508 | ||
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 23345436 | ||
| Pubmed | ABCF1 MYCBP2 SPTB TSG101 ACTN1 RAD54L2 PTPN13 CLTC QKI SMURF2 USP47 SETMAR SYNE1 TAF1C UBR4 CAMK1 ARHGAP5 MTA1 CTR9 PPP1R16B POLDIP2 TNKS2 | 8.21e-06 | 1285 | 205 | 22 | 35914814 | |
| Pubmed | ERCC2 MYCBP2 TSG101 PLXNB2 TTK MELK GGH DNAAF5 SYNE2 EIF3L CLTC GOPC UBR4 IGF2R FADS3 PRCP LNPEP GNA13 MDC1 PPA2 SERPINB1 CNOT1 | 9.49e-06 | 1297 | 205 | 22 | 33545068 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERCC2 PDE4A CLTCL1 MYCBP2 SRCAP PLXNB2 LYST GGA3 MDN1 PNPLA6 PTPRS SMURF2 CREB3 KHNYN UBR4 ICE1 IGF2R PPA2 PCNX1 GGA1 | 9.75e-06 | 1105 | 205 | 20 | 35748872 |
| Pubmed | ERCC2 NBN TSG101 SRCAP ACY1 PLEKHN1 DAP3 PNPLA6 ANKRD28 ZDHHC13 ANKRD52 TBX3 GOPC TAF1C RNF213 PRDM5 TADA1 MTA1 IL21R POLDIP2 | 1.13e-05 | 1116 | 205 | 20 | 31753913 | |
| Pubmed | Large-scale phage-based screening reveals extensive pan-viral mimicry of host short linear motifs. | 1.14e-05 | 24 | 205 | 4 | 37100772 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF1 MYCBP2 PRPF6 ACTN1 SRCAP MELK NCAPG2 NF1 MDN1 PNPLA6 EIF3L CLTC FEN1 PPP1R37 ANKRD28 ANKRD52 TTF2 TAF1C UBR4 SRRT CTR9 MDC1 | 1.82e-05 | 1353 | 205 | 22 | 29467282 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ERCC2 ABCF1 PRPF6 NCAPG2 MAP3K4 DAP3 EIF3L CLTC FEN1 TTF2 HSD17B7 PDPR UBR4 CPS1 CNOT1 | 2.10e-05 | 704 | 205 | 15 | 29955894 |
| Pubmed | 2.35e-05 | 10 | 205 | 3 | 15143060 | ||
| Pubmed | 2.48e-05 | 29 | 205 | 4 | 21829377 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CLTCL1 ABCA13 LYST ADAM28 ITPR1 RNF213 GRIK3 XPNPEP2 ASB14 LCP1 DCLRE1C PRCP ZNF554 | 2.72e-05 | 552 | 205 | 13 | 10737800 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 PRPF6 MELK EIF3L ANKRD28 QKI ANKRD52 USP47 TAF1C ICE1 USP46 TADA1 IGF2R GNA13 NUDCD1 OGA RPL3L CNOT1 | 3.17e-05 | 1005 | 205 | 18 | 19615732 |
| Pubmed | ABCF1 MYCBP2 PRPF6 ACTN1 RAD54L2 NCAPG2 CLTC FEN1 MED23 QKI TTF2 SATB2 GOPC FAM76B LCP1 JMJD1C MTA1 CTR9 CNOT1 | 3.22e-05 | 1103 | 205 | 19 | 34189442 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 25687912 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11792814 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 3.46e-05 | 2 | 205 | 2 | 11448776 | |
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 3.46e-05 | 2 | 205 | 2 | 24931616 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 38733588 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 7608176 | ||
| Pubmed | Altered Expression of EPO Might Underlie Hepatic Hemangiomas in LRRK2 Knockout Mice. | 3.46e-05 | 2 | 205 | 2 | 27872856 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 9295334 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 24376823 | ||
| Pubmed | Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure. | 3.46e-05 | 2 | 205 | 2 | 24014609 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 19804756 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 35022238 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 28692144 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 9520403 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 28368946 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 22768332 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 8733129 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 18794299 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 30846936 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 29097553 | ||
| Pubmed | Phosphoregulation of sorting signal-VHS domain interactions by a direct electrostatic mechanism. | 3.46e-05 | 2 | 205 | 2 | 12032548 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 3.46e-05 | 2 | 205 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 3.46e-05 | 2 | 205 | 2 | 24718612 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 24586179 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 26559190 | ||
| Pubmed | SYNE1-QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia. | 3.46e-05 | 2 | 205 | 2 | 32281752 | |
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 3.46e-05 | 2 | 205 | 2 | 20065094 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 17761684 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 31578382 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 30924193 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 18582474 | ||
| Pubmed | Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity. | 3.46e-05 | 2 | 205 | 2 | 27013965 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 16041389 | ||
| Pubmed | Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease. | 3.46e-05 | 2 | 205 | 2 | 23077216 | |
| Pubmed | ABCF1 DNAJC21 RAD54L2 NCAPG2 ITPR1 ANKRD28 DIP2B TBX3 ZDHHC17 JMJD1C KLHL11 SRRT CTR9 POLDIP2 | 3.54e-05 | 650 | 205 | 14 | 38777146 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYO5B LRRK2 IRF6 TSG101 ACTN1 ALDH1L1 ACY1 GGH PTPN13 CLTC XPNPEP2 LCP1 PKD1L3 CYRIB MSRA IGF2R PRCP SERPINB1 | 3.65e-05 | 1016 | 205 | 18 | 19056867 |
| Pubmed | 3.66e-05 | 104 | 205 | 6 | 9205841 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DCBLD1 PLEKHN1 TULP3 SLITRK2 NF1 NRK PPP1R37 ZDHHC13 DIP2B STIM2 GOPC IGF2R LNPEP | 3.71e-05 | 569 | 205 | 13 | 30639242 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | MBTPS1 PLXNB2 TTK ACSBG1 PIK3CB SYNE2 PITPNA EIF3L FEN1 LRP5L ZNF282 TAF1C UBR4 ICE1 JMJD1C CYRIB PRKAB1 POLDIP2 OGA | 4.15e-05 | 1124 | 205 | 19 | 21900206 |
| Pubmed | MBTPS1 INPP4A EXT1 HSD11B1L TTK NCAPG2 NF1 PIK3CB CLTC CNOT11 PSMF1 HSD17B7 UBR4 SPG11 TADA1 CTR9 GNA13 PRKAB1 MTBP OGA CNOT1 | 4.20e-05 | 1327 | 205 | 21 | 32694731 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 4.31e-05 | 157 | 205 | 7 | 30686591 | |
| Pubmed | CLTCL1 MYO5B DNAJC21 PRPF6 ACTN1 RAD54L2 SRCAP LYST DAP3 MDN1 SYNE2 CLTC SMURF2 STIM2 SYNE1 UBR4 SPG11 ZDHHC17 LCP1 CTR9 GNA13 RPL3L | 4.72e-05 | 1442 | 205 | 22 | 35575683 | |
| Pubmed | GPBP1 ACTN1 HSD11B1L PLXNB2 ITPR1 CLTC MED23 CREB3 LCA5 UBR4 IGF2R CTR9 | 4.91e-05 | 503 | 205 | 12 | 36217030 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | AGPAT3 EXT1 PRPF6 PLXNB2 ITPR1 GGH CLTC POMT2 STIM2 HSD17B7 PDPR GOPC RNF213 USP46 ZDHHC17 NMNAT3 SRRT IGF2R FADS3 LNPEP PPA2 POLDIP2 | 5.17e-05 | 1451 | 205 | 22 | 30550785 |
| Pubmed | 5.32e-05 | 35 | 205 | 4 | 23969696 | ||
| Pubmed | 5.35e-05 | 285 | 205 | 9 | 34369648 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSG101 RAD54L2 KDM5D TULP3 GGA3 CLTC PRUNE2 UBR4 MTA1 MDC1 ZMYM1 | 5.46e-05 | 430 | 205 | 11 | 35044719 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 5.61e-05 | 69 | 205 | 5 | 28481362 | |
| Pubmed | 5.96e-05 | 36 | 205 | 4 | 18830263 | ||
| Pubmed | 6.13e-05 | 225 | 205 | 8 | 12168954 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ABCF1 MYCBP2 NBN NF1 MDN1 PNPLA6 CLTC USP47 DIP2B FAM76B SRRT MTA1 CTR9 MDC1 OGA | 6.17e-05 | 774 | 205 | 15 | 15302935 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.20e-05 | 361 | 205 | 10 | 26167880 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 6.32e-05 | 226 | 205 | 8 | 25900982 | |
| Pubmed | Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. | 7.00e-05 | 14 | 205 | 3 | 23266556 | |
| Pubmed | MELK GGA3 ACSBG1 MED23 SATB2 PDPR SPG11 ICE1 MDC1 PCNX1 OGA CNOT1 | 7.93e-05 | 529 | 205 | 12 | 14621295 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYCBP2 PLXNB2 TTK ITPR1 DAP3 MDN1 SYNE2 CLTC QKI USP47 DIP2B TTF2 PDSS2 STIM2 PDPR GOPC SYNE1 UBR4 RNF213 ZDHHC17 PPA2 POLDIP2 | 8.06e-05 | 1496 | 205 | 22 | 32877691 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ABCF1 MYCBP2 TSG101 PRPF6 SRCAP GGH DAP3 PTPN13 CLTC FEN1 MED23 DIP2B SYNE1 FAM76B ZCCHC4 SRRT POLDIP2 CNOT1 | 8.14e-05 | 1082 | 205 | 18 | 38697112 |
| Pubmed | ABCF1 ACTN1 NCAPG2 DNAAF5 SSH3 EIF3L ZNF107 CPS1 SRRT ZNF100 ZSCAN22 | 8.35e-05 | 451 | 205 | 11 | 36168627 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 8.53e-05 | 121 | 205 | 6 | 31900314 | |
| Pubmed | NBN RAD54L2 NCAPG2 MDN1 MAD2L2 FANCL ICE1 JMJD1C SRRT TADA1 MDC1 | 8.68e-05 | 453 | 205 | 11 | 29656893 | |
| Interaction | C19orf38 interactions | 2.50e-06 | 86 | 203 | 8 | int:C19orf38 | |
| Interaction | PRKY interactions | 1.26e-05 | 140 | 203 | 9 | int:PRKY | |
| Cytoband | 6q26 | 6.81e-05 | 18 | 205 | 3 | 6q26 | |
| Cytoband | 11p15.3 | 1.10e-04 | 21 | 205 | 3 | 11p15.3 | |
| Cytoband | Xq22.3 | 4.34e-04 | 33 | 205 | 3 | Xq22.3 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.22e-04 | 36 | 129 | 4 | 823 | |
| GeneFamily | Golgi associated, gamma adaptin ear containing, ARF binding proteins | 1.51e-04 | 3 | 129 | 2 | 1031 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.00e-04 | 4 | 129 | 2 | 1252 | |
| GeneFamily | Ankyrin repeat domain containing | 3.48e-04 | 242 | 129 | 8 | 403 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 7.44e-04 | 6 | 129 | 2 | 699 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.04e-03 | 7 | 129 | 2 | 135 | |
| GeneFamily | CD molecules|Toll like receptors | 2.19e-03 | 10 | 129 | 2 | 948 | |
| GeneFamily | Patatin like phospholipase domain containing | 2.19e-03 | 10 | 129 | 2 | 466 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.19e-03 | 10 | 129 | 2 | 830 | |
| GeneFamily | CCR4-NOT transcription complex | 2.66e-03 | 11 | 129 | 2 | 1023 | |
| GeneFamily | ATP binding cassette subfamily A | 4.35e-03 | 14 | 129 | 2 | 805 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | AGBL5 TTK MELK NCAPG2 SYNE2 FANCL DEPDC1 KYAT1 DCLRE1C PCNX1 ZMYM1 | 3.85e-07 | 194 | 204 | 11 | M7467 |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP | AGPAT3 IRF6 ACTN1 MAP3K4 TXNDC16 ZNF282 SYNE1 PRDM5 ZCCHC4 IGF2R | 4.08e-06 | 200 | 204 | 10 | M7148 |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 4.08e-06 | 200 | 204 | 10 | M3188 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | GPBP1 MYCBP2 NBN EXT1 TTK ITPR1 GGH PTPN13 SYNE2 ZNF107 USP47 SPG11 DEPDC1 ARHGAP5 DCLRE1C ZMYM1 ZNF85 | 1.64e-05 | 656 | 204 | 17 | M18979 |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP | SRCAP MAP3K4 EIF3L AMMECR1 LCA5 XPNPEP2 PRDM5 TADA1 PPP1R16B | 2.65e-05 | 198 | 204 | 9 | M9305 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.18e-08 | 167 | 204 | 9 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.96e-07 | 185 | 204 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.05e-07 | 186 | 204 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-07 | 186 | 204 | 9 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.24e-07 | 188 | 204 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.80e-07 | 193 | 204 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.78e-07 | 200 | 204 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-06 | 168 | 204 | 8 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 171 | 204 | 8 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 175 | 204 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 178 | 204 | 8 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 2.11e-06 | 183 | 204 | 8 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 186 | 204 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 187 | 204 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-06 | 188 | 204 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 189 | 204 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 189 | 204 | 8 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 189 | 204 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 189 | 204 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 189 | 204 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | Control-cDC-|Control / Disease condition and Cell class | 3.38e-06 | 195 | 204 | 8 | a2b4d9473eff73f088b247ce43e66f013622471e | |
| ToppCell | Control-cDC|Control / Disease condition and Cell class | 3.38e-06 | 195 | 204 | 8 | b96acdd22dd3885af69328f170ea871a0d570034 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.65e-06 | 197 | 204 | 8 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.65e-06 | 197 | 204 | 8 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.79e-06 | 198 | 204 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_only / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 198 | 204 | 8 | 53c22e81e530d6fc272d4a45c8d1bf125feb254d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.93e-06 | 199 | 204 | 8 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.93e-06 | 199 | 204 | 8 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-05 | 168 | 204 | 7 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 171 | 204 | 7 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 172 | 204 | 7 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 172 | 204 | 7 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 172 | 204 | 7 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 174 | 204 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 174 | 204 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 175 | 204 | 7 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 176 | 204 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 179 | 204 | 7 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-05 | 179 | 204 | 7 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 180 | 204 | 7 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 180 | 204 | 7 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 181 | 204 | 7 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 181 | 204 | 7 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 181 | 204 | 7 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 183 | 204 | 7 | 20f7b6ec2462032eda957a893ca76d5a5a01333d | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.28e-05 | 184 | 204 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.53e-05 | 187 | 204 | 7 | e1d6c1194476cf26969e405b0951796fed519f44 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 188 | 204 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.62e-05 | 188 | 204 | 7 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 189 | 204 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.80e-05 | 190 | 204 | 7 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-05 | 190 | 204 | 7 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.80e-05 | 190 | 204 | 7 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.89e-05 | 191 | 204 | 7 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.89e-05 | 191 | 204 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.89e-05 | 191 | 204 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-05 | 192 | 204 | 7 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.99e-05 | 192 | 204 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.09e-05 | 193 | 204 | 7 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.09e-05 | 193 | 204 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.09e-05 | 193 | 204 | 7 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 193 | 204 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-05 | 194 | 204 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 194 | 204 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 3.30e-05 | 195 | 204 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 3.30e-05 | 195 | 204 | 7 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.30e-05 | 195 | 204 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 196 | 204 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-05 | 196 | 204 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.52e-05 | 197 | 204 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 3.52e-05 | 197 | 204 | 7 | 59ddd8ff7dddf3747b988374e1a4d80959db803e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-05 | 197 | 204 | 7 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Control-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 3.52e-05 | 197 | 204 | 7 | e0ee15188ff0d9df3c3b5ea523553ce18d223c33 | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.64e-05 | 198 | 204 | 7 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.64e-05 | 198 | 204 | 7 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 198 | 204 | 7 | d11097254791e415bf60a847feac81f400f11664 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 198 | 204 | 7 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 199 | 204 | 7 | 3d876f172487425b37b2f658dae59e0f293ee76e | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 3.76e-05 | 199 | 204 | 7 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.76e-05 | 199 | 204 | 7 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-05 | 199 | 204 | 7 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 3.88e-05 | 200 | 204 | 7 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-05 | 200 | 204 | 7 | 14c9ced92763858f3d35186cd3908bd0f4cfd872 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.88e-05 | 200 | 204 | 7 | 9744d53915c8dc9d5e011cbbb0ac7db44c615ce7 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-DCs|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.88e-05 | 200 | 204 | 7 | 6237e4b46b196e1d1610b2edc60af4716a6fed25 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 3.88e-05 | 200 | 204 | 7 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 3.88e-05 | 200 | 204 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.88e-05 | 200 | 204 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 3.88e-05 | 200 | 204 | 7 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC-DCs-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.88e-05 | 200 | 204 | 7 | b52f7534a5ff504dccc002ebc30836a87e43c123 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-05 | 200 | 204 | 7 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 3.88e-05 | 200 | 204 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 3.88e-05 | 200 | 204 | 7 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-cDC-DCs|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.88e-05 | 200 | 204 | 7 | cb0ba75be8fb2ec47474559911df80d085c4dbc8 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 143 | 204 | 6 | 0cd332c128710291a39957d3da22953352f5c382 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-05 | 146 | 204 | 6 | 24e63124116b9a6796ae0495fc69dc6b6af28c38 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | AGPAT3 EXT1 RAD54L2 ITPR1 PIK3CB ZNF107 KYAT1 ZCCHC4 PRKAB1 ZMYM1 ZNF85 | 1.75e-06 | 198 | 203 | 11 | 5880_DN |
| Disease | Colorectal Carcinoma | ERCC2 ABCA13 ALDH1L1 ADARB2 ABCA10 GGH NF1 PTPRS FEN1 UGT3A2 QKI SATB2 SYNE1 CAPN6 GRIK3 LGR5 | 2.96e-05 | 702 | 202 | 16 | C0009402 |
| Disease | docosapentaenoic acid measurement | 3.31e-05 | 27 | 202 | 4 | EFO_0006809 | |
| Disease | Acquired Polyneuropathy | 1.39e-04 | 3 | 202 | 2 | C0751449 | |
| Disease | Polyneuropathy, Familial | 1.39e-04 | 3 | 202 | 2 | C0751448 | |
| Disease | Polyneuropathy, Motor | 1.39e-04 | 3 | 202 | 2 | C0271683 | |
| Disease | Polyneuropathy, Critical Illness | 1.39e-04 | 3 | 202 | 2 | C0393851 | |
| Disease | anti-Helicobacter pylori serum IgG measurement | 1.39e-04 | 3 | 202 | 2 | EFO_0005247 | |
| Disease | citrate measurement | 2.14e-04 | 79 | 202 | 5 | EFO_0010114 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.55e-04 | 45 | 202 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.55e-04 | 45 | 202 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | common variable immunodeficiency (is_implicated_in) | 2.77e-04 | 4 | 202 | 2 | DOID:12177 (is_implicated_in) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.77e-04 | 4 | 202 | 2 | cv:CN293514 | |
| Disease | Polyneuropathy | 2.77e-04 | 4 | 202 | 2 | C0152025 | |
| Disease | Parkinson Disease | 3.01e-04 | 85 | 202 | 5 | C0030567 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.60e-04 | 5 | 202 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.60e-04 | 5 | 202 | 2 | C0410190 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.05e-04 | 145 | 202 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, factor VII measurement | 6.77e-04 | 58 | 202 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | Colorectal Neoplasms | 6.80e-04 | 277 | 202 | 8 | C0009404 | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.87e-04 | 6 | 202 | 2 | cv:C0410189 | |
| Disease | brain disease (implicated_via_orthology) | 6.87e-04 | 6 | 202 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.87e-04 | 6 | 202 | 2 | C0410189 | |
| Disease | forced expiratory volume, environmental tobacco smoke exposure measurement | 6.87e-04 | 6 | 202 | 2 | EFO_0004314, EFO_0008361 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 7.28e-04 | 103 | 202 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Pancytopenia | 7.32e-04 | 26 | 202 | 3 | C0030312 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 9.30e-04 | 224 | 202 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | fibrinogen measurement | 9.40e-04 | 109 | 202 | 5 | EFO_0004623 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.57e-04 | 7 | 202 | 2 | C0751337 | |
| Disease | cholesterol in large VLDL measurement | 1.04e-03 | 65 | 202 | 4 | EFO_0021902 | |
| Disease | lipoprotein A measurement | 1.06e-03 | 112 | 202 | 5 | EFO_0006925 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.17e-03 | 67 | 202 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Huntington's disease (implicated_via_orthology) | 1.35e-03 | 32 | 202 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 38:5 measurement | 1.48e-03 | 33 | 202 | 3 | EFO_0010387 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.50e-03 | 121 | 202 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.63e-03 | 9 | 202 | 2 | OBA_2045127 | |
| Disease | metabolite measurement | CLTCL1 ALDH1L1 HOGA1 SYNE2 ICE1 CERS6 CPS1 LCP1 KYAT1 IGF2R ZMYM1 | 1.75e-03 | 560 | 202 | 11 | EFO_0004725 |
| Disease | triacylglycerol 52:4 measurement | 1.91e-03 | 36 | 202 | 3 | EFO_0010416 | |
| Disease | triacylglycerol 56:8 measurement | 1.91e-03 | 36 | 202 | 3 | EFO_0010435 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 2.02e-03 | 10 | 202 | 2 | EFO_0800333 | |
| Disease | cholesteryl ester measurement | 2.04e-03 | 257 | 202 | 7 | EFO_0010351 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0800332 | |
| Disease | Inherited neuropathies | 2.59e-03 | 40 | 202 | 3 | C0598589 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.78e-03 | 41 | 202 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.78e-03 | 41 | 202 | 3 | C0858252 | |
| Disease | epilepsy | 2.78e-03 | 41 | 202 | 3 | EFO_0000474 | |
| Disease | Oligodontia | 2.94e-03 | 12 | 202 | 2 | C4082304 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.94e-03 | 12 | 202 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | high grade glioma (is_implicated_in) | 2.98e-03 | 42 | 202 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ADAMTS19 RTP1 DNAJC21 NBN ACY1 INPP4B GGA3 DAP3 NF1 PIK3CB SYNE2 TBX3 SYNE1 UBR4 GRIK3 GGA1 | 3.08e-03 | 1074 | 202 | 16 | C0006142 |
| Disease | sphingomyelin measurement | 3.16e-03 | 278 | 202 | 7 | EFO_0010118 | |
| Disease | ejection fraction measurement | 3.19e-03 | 43 | 202 | 3 | EFO_0005527 | |
| Disease | triglycerides in large LDL measurement | 3.19e-03 | 43 | 202 | 3 | EFO_0022319 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.19e-03 | 144 | 202 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Anemia, Hemolytic, Acquired | 3.46e-03 | 13 | 202 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 3.46e-03 | 13 | 202 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 3.46e-03 | 13 | 202 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 3.46e-03 | 13 | 202 | 2 | C0221021 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 3.46e-03 | 13 | 202 | 2 | OBA_2045116 | |
| Disease | Skin Abnormalities | 3.46e-03 | 13 | 202 | 2 | C0037268 | |
| Disease | obesity (implicated_via_orthology) | 3.75e-03 | 215 | 202 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 3.80e-03 | 150 | 202 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | Hypodontia | 4.02e-03 | 14 | 202 | 2 | C0020608 | |
| Disease | N-acetylglycine measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0021002 | |
| Disease | diacylglycerol 38:4 measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0020066 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.05e-03 | 291 | 202 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | fibrinogen measurement, coronary artery disease | 4.25e-03 | 154 | 202 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.38e-03 | 222 | 202 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.61e-03 | 157 | 202 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | glycerophospholipid measurement | 4.62e-03 | 49 | 202 | 3 | EFO_0007630 | |
| Disease | cholesteryl ester 20:3 measurement | 4.62e-03 | 49 | 202 | 3 | EFO_0010347 | |
| Disease | disease recurrence, colon carcinoma | 5.17e-03 | 51 | 202 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | ureidopropionic acid measurement | 5.25e-03 | 16 | 202 | 2 | EFO_0010542 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 5.25e-03 | 16 | 202 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | diacylglycerol 36:2 measurement | 5.25e-03 | 16 | 202 | 2 | EFO_0010355 | |
| Disease | household income, smoking status measurement, educational attainment, protein intake measurement, carbohydrate intake measurement, alcohol consumption measurement, body mass index, energy intake measurement | 5.25e-03 | 16 | 202 | 2 | EFO_0004340, EFO_0006527, EFO_0007878, EFO_0009374, EFO_0009695, EFO_0010810, EFO_0010811, EFO_0011015 | |
| Disease | cholesterol in small VLDL measurement | 5.76e-03 | 53 | 202 | 3 | EFO_0022228 | |
| Disease | lymphocyte count | EPO PDE4A PDE4D SPTB CDH23 NBN PLXNB2 LYST INPP4B ITPR1 ACSBG1 TTF2 CERS6 CPS1 LCP1 JMJD1C CYRIB DCLRE1C PPA2 | 5.80e-03 | 1464 | 202 | 19 | EFO_0004587 |
| Disease | muscular dystrophy (is_implicated_in) | 5.93e-03 | 17 | 202 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Moyamoya Disease | 5.93e-03 | 17 | 202 | 2 | C0026654 | |
| Disease | sphingomyelin 14:0 measurement | 5.93e-03 | 17 | 202 | 2 | EFO_0010390 | |
| Disease | Limb Deformities, Congenital | 5.93e-03 | 17 | 202 | 2 | C0206762 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.95e-03 | 105 | 202 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | total lipids in medium VLDL | 6.07e-03 | 54 | 202 | 3 | EFO_0022153 | |
| Disease | plasminogen activator inhibitor 1 measurement | 6.07e-03 | 54 | 202 | 3 | EFO_0004792 | |
| Disease | response to TNF antagonist | 6.07e-03 | 54 | 202 | 3 | EFO_0004653 | |
| Disease | platelet component distribution width | LRRK2 ACTN1 INPP4B ANKRD28 QKI PRUNE2 SYNE1 CPS1 LCP1 JMJD1C TADA1 PPP1R16B | 6.07e-03 | 755 | 202 | 12 | EFO_0007984 |
| Disease | Ischemic stroke, fibrinogen measurement | 6.38e-03 | 55 | 202 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Diffuse Large B-Cell Lymphoma | 6.38e-03 | 55 | 202 | 3 | C0079744 | |
| Disease | Bone marrow hypocellularity | 6.64e-03 | 18 | 202 | 2 | C1855710 | |
| Disease | diacylglycerol 36:3 measurement | 6.64e-03 | 18 | 202 | 2 | EFO_0020062 | |
| Disease | schizophrenia, inflammatory bowel disease | 6.64e-03 | 18 | 202 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 6.64e-03 | 18 | 202 | 2 | OBA_2045079 | |
| Disease | triglycerides in large VLDL measurement | 6.71e-03 | 56 | 202 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 6.71e-03 | 56 | 202 | 3 | EFO_0022320 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.71e-03 | 56 | 202 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | IGF-1 measurement | 6.73e-03 | 488 | 202 | 9 | EFO_0004627 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADRHNAEAWKQTEPA | 381 | Q8NDL9 | |
| DEPTNHLDLNAVIWL | 476 | Q8NE71 | |
| TPQEINGKWDHVRQL | 596 | P12814 | |
| LQAADPAISQAWIKH | 446 | Q86VW2 | |
| ASHWKQAAVVLDNPI | 806 | Q6P2P2 | |
| HTEILKLFPQAAWQE | 1451 | Q8WWZ4 | |
| WAHDLQQNIALPATK | 176 | Q9UKQ2 | |
| HWETEFKPVAQQLLN | 836 | Q8NEN0 | |
| NARDKNWQTPLHIAA | 101 | O15084 | |
| QDHFQEIEKIWSSPN | 2981 | Q86UQ4 | |
| EIGWIPLHKAAVQLN | 81 | A6NK59 | |
| IWNHPDVLYEALQKE | 621 | Q9Y4B4 | |
| IWIHQDTPQDSLDKT | 51 | Q6P1W5 | |
| HSADVNARDKLWQTP | 96 | Q8NB46 | |
| NARDKLWQTPLHVAA | 101 | Q8NB46 | |
| KNDGHLEPVTAWEVQ | 281 | Q7Z5J1 | |
| PAHWNQVVSEAEKIV | 46 | Q86YH6 | |
| ITLLDINDNHPTWKD | 766 | Q9H251 | |
| RNLDGQKEWVHVAPL | 156 | Q8IUZ5 | |
| KRGIHDASIPQWEND | 726 | Q9BYT9 | |
| VDWHFLLESQAPKTI | 411 | Q16853 | |
| RVTLQEWNDPLDHDL | 711 | O43374 | |
| EWNDPLDHDLEAQLI | 716 | O43374 | |
| RVTLQEWNDPLDHDL | 711 | C9J798 | |
| EWNDPLDHDLEAQLI | 716 | C9J798 | |
| KPNWEHLNEDLHVLI | 141 | Q96PU8 | |
| SWSVAPKNALVQLHE | 121 | Q9NS39 | |
| IETWHKPDLGTQENV | 111 | Q00169 | |
| SPKHILQWQAVLDEE | 706 | Q8TE59 | |
| PAHDKLWNQLEAEIH | 231 | Q9HD26 | |
| PQAFWTKHAQTEIIE | 76 | Q96PE3 | |
| EELLKVFWENHDPTQ | 131 | Q9UJ68 | |
| VDALLWQPHSSKQDD | 461 | Q96RS6 | |
| WLRFVHEAPSQEQKN | 81 | Q9NQX1 | |
| VEWQSKNPFIHLDDD | 271 | Q14680 | |
| IWLTDKQPEEHNFSD | 201 | Q6NSI4 | |
| QEKNHPWLELSDVHR | 221 | Q9Y2S7 | |
| HRVFQDKQIEDLWLP | 1071 | Q8IY17 | |
| EPTEKEYDWLQHLAN | 1286 | Q9NU22 | |
| QWEDAQKLQHRLIEP | 261 | Q86XE5 | |
| IKDFPWILADEQDVH | 166 | Q9UI95 | |
| LAHLKESQPAIWNRD | 416 | Q14676 | |
| AIDPEDKWHQRAQQL | 311 | Q6NUN7 | |
| HPFVDKVWELTANNV | 316 | Q14703 | |
| NTWVHSTNIPIDKEE | 396 | Q14643 | |
| REPNHNKSLAAGVWE | 146 | Q86WP2 | |
| EIDFLRSNPKIWNVH | 211 | Q9Y262 | |
| QEIKELGELSPHWDN | 281 | O15327 | |
| QSPLHWLADLAEQKA | 2006 | Q15652 | |
| QWLDEVKQALAPSAH | 916 | Q9BY66 | |
| ISNPEHLTEWLQSVK | 921 | Q8IY21 | |
| VSEKPQGLSHQEWID | 1141 | Q5CZC0 | |
| LQEAIDNVLAWIHPD | 61 | Q86V42 | |
| EKNLVIAHEGDPAWR | 1886 | Q96RV3 | |
| ALHKPENQDIDWGAL | 376 | P13796 | |
| QDEDTIHIWKTNSLP | 1671 | O15031 | |
| EIQNLQEDWDHFEPL | 321 | Q8NCN5 | |
| TWADLVHPDAQEILD | 656 | P27815 | |
| WADLVHPDAQDILDT | 686 | Q08499 | |
| SDFVKENSPEHWLQN | 901 | Q9ULK4 | |
| HDPQISKSLEWNGAI | 61 | Q8TC05 | |
| LQNKSDDLPHWVLSA | 236 | Q5TB30 | |
| LAEILQWRAQATPDH | 991 | Q9P265 | |
| PLTSQDIQHLKDWIS | 266 | P42785 | |
| QASLEGATQPHKEWV | 301 | Q8N8W4 | |
| TKINDPDDIAVNWVA | 31 | A4QPB2 | |
| GQHRQVLVWKDLDSP | 736 | O75581 | |
| WDINLPHEVQNLEKH | 2496 | Q5S007 | |
| NLSPEEEQGLWKQSH | 191 | Q5HYJ3 | |
| GKLPRWIQEHLTDAN | 691 | P18074 | |
| NKWEEPGHLTLDLQS | 356 | Q86VQ0 | |
| DDDWEALIHQLKINP | 706 | Q9UIQ6 | |
| LAHKIQSPQEWEAIQ | 51 | Q9UJY5 | |
| AHKIQSPQEWEALQA | 51 | Q9NZ52 | |
| IPEKHINHAAALQWT | 471 | Q9Y4A0 | |
| DAREKLHIPWGDNSN | 101 | Q14344 | |
| LALKWHPDKNLDNAA | 26 | Q5F1R6 | |
| ITWHKDGQPLQEDEA | 2511 | Q96RW7 | |
| PVGNWQKHNVDDSLL | 471 | Q13332 | |
| PKDPWRHAQNVTVDE | 61 | O75864 | |
| EHKLQFWAVTAENEP | 261 | P04062 | |
| LQHPWIAGDTALDKN | 271 | Q14012 | |
| NVNAKDNELWTPLHA | 126 | Q96T49 | |
| NIHPWVKQIDTLAAE | 936 | P31327 | |
| PENWLHKEAHQLFLE | 271 | P39748 | |
| WEEKPKSHEAIQALN | 416 | Q9Y2F5 | |
| VTVYNPELDKWHNLE | 471 | Q9NVR0 | |
| VLHLQKADGDVPQWE | 476 | Q96SD1 | |
| VPWDQLENEDSSVHI | 66 | Q16394 | |
| EWKNLDGISHAPNAV | 251 | Q92820 | |
| SDWFKEALQINQDHP | 551 | Q6PD62 | |
| SPKEAENLPLWQHIS | 521 | Q9NSG2 | |
| SSQPWEPLQLHVDKA | 111 | P01588 | |
| KVQEAVLDKWVNDPH | 216 | Q9H4A6 | |
| LELSVPEKVNNAQWD | 61 | Q96GR2 | |
| PHNVTWADLKNTEEA | 16 | Q6ZMG9 | |
| EALVWLFHQKPESLN | 266 | P56937 | |
| EKVVKIPENHNFDWQ | 1556 | Q0VDD8 | |
| ESQENIFLPSKWQHL | 1581 | Q99698 | |
| LVHDPANWVSVDKNS | 431 | Q8IXH8 | |
| HIWLQLEGPKENASR | 51 | O15037 | |
| AIQHPADEKLQEKAW | 66 | Q9NUQ9 | |
| HEWTKPENLDFIEVN | 256 | P30740 | |
| QSEELKEGWNPHLLL | 226 | Q9HBE5 | |
| ETVTKDILAPNLQWH | 651 | Q86Y56 | |
| PLEEKHSAENNWIEE | 151 | Q4LDG9 | |
| NNHKPREWLEIDLGE | 306 | Q8N8Z6 | |
| NVDNPHVSAIVEKWS | 286 | Q13003 | |
| IPNHKEQEWDPQKTE | 101 | Q9Y6Q1 | |
| ALQSEVPKDSTHQWL | 281 | O43889 | |
| EQIRAHDQPGDKWLV | 26 | Q9Y5Q0 | |
| QPEKGTELQFEHLNW | 531 | Q9P1V8 | |
| LKWQHEEAAEAPSLA | 806 | Q13474 | |
| SGIITPIHEQWEKAN | 136 | Q92530 | |
| EDPEYDVQSKQWLTH | 331 | Q3KNS1 | |
| HLWLDDNALTEIPVQ | 166 | O75473 | |
| WPERHVLQNLETFEK | 556 | Q96DY7 | |
| NWTPLKNDLENHLED | 1766 | Q12923 | |
| DPNIQDKEGRTALHW | 481 | Q9Y283 | |
| IPWKHGLRQDAQQED | 36 | Q14653 | |
| HSPQQEEENTIFKAW | 46 | O14896 | |
| QALLETSHQWPKQRE | 311 | Q6ZUA9 | |
| VAAKARAHILPWVDN | 386 | Q6ZUA9 | |
| PQASHSLKNLLEEEW | 716 | Q9Y6R4 | |
| HLTWLRNKILNNDPE | 1276 | Q7Z2Y5 | |
| LSALVRHAEPEQNWE | 486 | P11717 | |
| LENNWLQHEKAPTEE | 361 | P51398 | |
| DSWDLIIDPNLKHNV | 61 | P59025 | |
| SRVKLQHLPAQEQWD | 226 | Q494U1 | |
| PAHRITAKELLDNQW | 366 | Q9BYT3 | |
| DDPKVHLEAKELWDQ | 101 | O15119 | |
| EDHDEALKNTWNLHP | 806 | Q8WUY3 | |
| TLNSIWNVEDHINPK | 511 | Q9UKY4 | |
| SEHDSLWVKNELIPN | 641 | Q9BXR5 | |
| PEHKEINHLNDQWLD | 4206 | Q8NF91 | |
| HWLKQADIVTFPEIN | 4576 | Q8NF91 | |
| KEVPFETLAQWNLEH | 611 | Q8WXH0 | |
| KQWETLEPLHLEAEN | 2711 | Q8WXH0 | |
| TKLWHPNHEELQQDK | 306 | Q96BN2 | |
| KLSRNIHLWDPENSV | 266 | Q9NW38 | |
| IHLWDPENSVLQNLK | 271 | Q9NW38 | |
| WKNKEQHLSENEPVD | 501 | O60934 | |
| IKRAPVIWDNIHAND | 271 | O60502 | |
| WAQARLEKQVPVHSV | 196 | Q92901 | |
| ALEHVPNSVRLWKAA | 396 | O94906 | |
| PFNLTKTIQQDEWHL | 156 | Q8NBL3 | |
| ENGALHVTKDLLWEP | 46 | Q15572 | |
| TWKEHLVQATPENLQ | 331 | Q06033 | |
| NPWVEFVKLASEHDV | 16 | Q16773 | |
| KDEEYTWVLNPEHLQ | 586 | Q7Z443 | |
| KLEDLPAEQWNHATV | 161 | Q9UPW6 | |
| KDWTEHANSPVIINE | 541 | Q9H156 | |
| LDKWVPHELTENQKN | 456 | Q53H47 | |
| PKLTSVHENLNSWIE | 2081 | O75592 | |
| PNLEEIEHLNWSEAL | 351 | Q13017 | |
| DWKLIAINANDPEAS | 201 | Q9H2U2 | |
| SSPNKESNEEEQVWH | 316 | Q9H2U2 | |
| TQVWEAHNPLTDKQI | 196 | Q13330 | |
| SEVSGKNDHIWNEPL | 371 | P42338 | |
| KNDHIWNEPLEFDIN | 376 | P42338 | |
| VTQRNKQPWHPDEDD | 386 | Q6ZRS2 | |
| HDSFWVKNELLPNLE | 646 | Q15399 | |
| HNVRLWDEESAQLLP | 376 | Q8TE77 | |
| PNRISHGEVLEWQKT | 651 | Q9BXP5 | |
| KNISDIHPESFNLQW | 131 | Q53R12 | |
| LAWQHDLEVNDKAPA | 61 | Q9Y478 | |
| PAEAIHNWIRGNDKV | 216 | O75891 | |
| EKEWQRLQSNPHLKE | 231 | Q03154 | |
| LPEVAKEQGWDHIQT | 256 | Q9Y4X0 | |
| PKVLRAAEQAHLWAE | 1346 | Q00610 | |
| PKVLRAAEQAHLWAE | 1346 | P53675 | |
| HFTVDKQNISLWPRE | 11 | Q9UJ71 | |
| VDNWLPTEHAQAKSN | 726 | Q86XI2 | |
| LNPTEPDHAIQWDKS | 301 | Q9UKZ1 | |
| QVWPEANQHFSKEID | 831 | A5YKK6 | |
| EWKHPQSDLLGLIQV | 116 | Q99816 | |
| DPDLHNSLVWILEND | 526 | Q9HAU4 | |
| IESQPWEDSLKDGHQ | 2246 | Q96JI7 | |
| KKQEESQFHPLEWLA | 3591 | Q63HN8 | |
| HFAQDLWPEQNIKDS | 11 | Q9UII5 | |
| SHFPQDLWAEQDIKD | 111 | Q8IYN0 | |
| GLENHITILPAQEWK | 726 | Q9P2K2 | |
| RQPDKENVSLLHWAA | 76 | Q8IUH4 | |
| EDIPLDEKEAAQWLH | 261 | Q9NRZ7 | |
| NHLDSWIPDTNDEKV | 106 | A0A1B0GUW6 | |
| QLKSLIQIDLHDNPW | 551 | O94991 | |
| SVPDALQKWLQLTHE | 346 | Q9P246 | |
| SDSEIQLTWKHPEAL | 656 | P35590 | |
| VGLLNHQWLKETDVP | 61 | Q8TAQ9 | |
| LQKAADPWVLKHSEL | 876 | O94964 | |
| DPWVLKHSELEKQDN | 881 | O94964 | |
| LDIHQDLDWNPKVST | 1286 | Q96K76 | |
| VLHQLDSIDLWNPDA | 551 | P21359 | |
| AFLEHLWKNLQDPSN | 6 | Q2M238 | |
| NDTSVHWFPVQKLEQ | 291 | Q9UH36 | |
| HPQIEARIKEVSAQW | 711 | P11277 | |
| NVADLWKFTPLHEAA | 586 | Q9H2K2 | |
| PDKENVTLLHWAAIN | 86 | Q8IUH5 | |
| QWLQPEAHSKEQILE | 76 | P10073 | |
| EPAENNKPELTWVHE | 156 | P62068 | |
| VDFSKEEWQHLDPAQ | 76 | P51814 | |
| HWQIPELARKVNTEQ | 406 | P33981 | |
| QSQDDSHKELPIFWI | 301 | Q9H5U6 | |
| HFAQDLWPEQNIKDS | 81 | Q03923 | |
| EEFEWLQQHTEPLAA | 636 | O43895 | |
| WNEPLNETTAKHVQE | 1001 | Q5SVZ6 | |
| HLAANVKIVDWLPQS | 341 | Q3SY77 | |
| DHGLLPREEWQAKVA | 71 | Q92748 | |
| LLIWQHKASAQGDPD | 761 | Q5T4S7 | |
| HADLKPRNILWSAEN | 156 | Q8TAS1 | |
| ENLVELHNKAPVWNS | 356 | O75386 | |
| AHDILSWIKQEEQPY | 361 | Q9UDV7 | |
| WARIILDEAHNVKNP | 731 | Q9UNY4 | |
| WKQLEDSHEDPQGLL | 186 | Q86TJ5 | |
| ASQLLEHPENLAWID | 71 | Q96E66 | |
| DEEIIQNWHLPERFK | 161 | A6PVS8 | |
| WPNSEKHVDQEDAIE | 1291 | Q9ULV0 | |
| TFQTPNLWKDAHIQE | 141 | Q96T66 |